1. 408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors. (9th November 2020) Authors: Harrington, Kevin; Parkes, Eileen; Weiss, Jared; Ingham, Mathew; Cervantes, Andrés; Calvo, Emiliano; Riese, Matthew; Klinkhardt, Ute; Sikken, Patricia; Schmohl, Michael; Garralda, Elena Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗